• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

方差未知的正态分布下的条件无偏估计。

Conditionally unbiased estimation in the normal setting with unknown variances.

作者信息

Robertson David S, Glimm Ekkehard

机构信息

MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.

Novartis Pharma AG, Novartis Campus, Basel, Switzerland.

出版信息

Commun Stat Theory Methods. 2018 Jan 5;48(3):616-627. doi: 10.1080/03610926.2017.1417429. eCollection 2019.

DOI:10.1080/03610926.2017.1417429
PMID:31217751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6540744/
Abstract

To efficiently and completely correct for selection bias in adaptive two-stage trials, uniformly minimum variance conditionally unbiased estimators (UMVCUEs) have been derived for trial designs with normally distributed data. However, a common assumption is that the variances are known exactly, which is unlikely to be the case in practice. We extend the work of Cohen and Sackrowitz (, 8(3):273-278, 1989), who proposed an UMVCUE for the best performing candidate in the normal setting with a common variance. Our extension allows for multiple selected candidates, as well as unequal stage one and two sample sizes.

摘要

为了在适应性两阶段试验中有效且完全地校正选择偏倚,针对具有正态分布数据的试验设计,已经推导出了一致最小方差条件无偏估计量(UMVCUEs)。然而,一个常见的假设是方差是精确已知的,而在实际中不太可能如此。我们扩展了科恩和萨克罗维茨(Cohen and Sackrowitz,《统计与概率快报》,8(3):273 - 278,1989)的工作,他们针对具有共同方差的正态设定下表现最佳的候选者提出了一个UMVCUE。我们的扩展允许有多个选定的候选者,以及第一阶段和第二阶段样本量不相等的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/643a/6540744/dd5e2ee578fc/LSTA_A_1417429_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/643a/6540744/38faa597c950/LSTA_A_1417429_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/643a/6540744/bca5a82fecae/LSTA_A_1417429_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/643a/6540744/ee6bdf84daa3/LSTA_A_1417429_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/643a/6540744/16b59e1c11ee/LSTA_A_1417429_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/643a/6540744/dd5e2ee578fc/LSTA_A_1417429_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/643a/6540744/38faa597c950/LSTA_A_1417429_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/643a/6540744/bca5a82fecae/LSTA_A_1417429_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/643a/6540744/ee6bdf84daa3/LSTA_A_1417429_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/643a/6540744/16b59e1c11ee/LSTA_A_1417429_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/643a/6540744/dd5e2ee578fc/LSTA_A_1417429_F0005_OC.jpg

相似文献

1
Conditionally unbiased estimation in the normal setting with unknown variances.方差未知的正态分布下的条件无偏估计。
Commun Stat Theory Methods. 2018 Jan 5;48(3):616-627. doi: 10.1080/03610926.2017.1417429. eCollection 2019.
2
Conditionally unbiased and near unbiased estimation of the selected treatment mean for multistage drop-the-losers trials.多阶段淘汰失败者试验中所选治疗均值的条件无偏和近似无偏估计。
Biom J. 2014 Mar;56(2):332-49. doi: 10.1002/bimj.201200245. Epub 2013 Dec 18.
3
Accounting for selection and correlation in the analysis of two-stage genome-wide association studies.在两阶段全基因组关联研究分析中考虑选择和相关性
Biostatistics. 2016 Oct;17(4):634-49. doi: 10.1093/biostatistics/kxw012. Epub 2016 Mar 18.
4
Unbiased estimation of selected treatment means in two-stage trials.两阶段试验中选定治疗均值的无偏估计。
Biom J. 2008 Aug;50(4):515-27. doi: 10.1002/bimj.200810442.
5
Adjusting for treatment selection in phase II/III clinical trials with time to event data.调整具有生存时间数据的 II/III 期临床试验中的治疗选择。
Stat Med. 2023 Jan 30;42(2):146-163. doi: 10.1002/sim.9606. Epub 2022 Nov 23.
6
Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.在具有不等治疗效果方差和假设驱动选择规则的无缝II/III期试验中的无偏估计。
Stat Med. 2016 Sep 30;35(22):3907-22. doi: 10.1002/sim.6974. Epub 2016 Apr 21.
7
Estimation of the selected treatment mean in two stage drop-the-losers design.两阶段剔除失败者设计中选定治疗均值的估计。
J Biopharm Stat. 2024 Mar;34(2):164-189. doi: 10.1080/10543406.2023.2183962. Epub 2023 Mar 5.
8
Point estimation in adaptive enrichment designs.适应性富集设计中的点估计
Stat Med. 2017 Nov 10;36(25):3935-3947. doi: 10.1002/sim.7412. Epub 2017 Aug 7.
9
Least squares Lehmann-Scheffé estimation of variances and covariances with mixed linear models.混合线性模型中方差和协方差的最小二乘Lehmann-Scheffé估计
J Anim Sci. 1996 Nov;74(11):2577-85. doi: 10.2527/1996.74112577x.
10
Conditional estimation in two-stage adaptive designs.两阶段适应性设计中的条件估计
Biometrics. 2017 Sep;73(3):895-904. doi: 10.1111/biom.12642. Epub 2017 Jan 18.

引用本文的文献

1
Statistical Inference for a Two-Stage Adaptive Seamless Design Using Different Binary Endpoints.使用不同二元终点的两阶段自适应无缝设计的统计推断
Stat Med. 2025 Mar 15;44(6):e70003. doi: 10.1002/sim.70003.
2
Point estimation for adaptive trial designs I: A methodological review.自适应试验设计的点估计 I:方法学综述。
Stat Med. 2023 Jan 30;42(2):122-145. doi: 10.1002/sim.9605. Epub 2022 Nov 30.
3
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.针对COVID-19干预措施临床试验的高效自适应设计

本文引用的文献

1
Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.在具有不等治疗效果方差和假设驱动选择规则的无缝II/III期试验中的无偏估计。
Stat Med. 2016 Sep 30;35(22):3907-22. doi: 10.1002/sim.6974. Epub 2016 Apr 21.
2
Accounting for selection and correlation in the analysis of two-stage genome-wide association studies.在两阶段全基因组关联研究分析中考虑选择和相关性
Biostatistics. 2016 Oct;17(4):634-49. doi: 10.1093/biostatistics/kxw012. Epub 2016 Mar 18.
3
Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility.
Stat Biopharm Res. 2020 Jul 29;12(4):483-497. doi: 10.1080/19466315.2020.1790415.
有条件无偏估计在具有无效性提前停止的 II/III 期临床试验中。
Stat Med. 2013 Jul 30;32(17):2893-910. doi: 10.1002/sim.5757. Epub 2013 Feb 15.
4
Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium.每日一次的支气管扩张剂治疗慢性阻塞性肺疾病:茚达特罗与噻托溴铵。
Am J Respir Crit Care Med. 2010 Jul 15;182(2):155-62. doi: 10.1164/rccm.200910-1500OC. Epub 2010 May 12.
5
Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design.在 COPD 临床研究中使用适应性无缝设计整合茚达特罗剂量选择。
Pulm Pharmacol Ther. 2010 Jun;23(3):165-71. doi: 10.1016/j.pupt.2010.01.003. Epub 2010 Jan 18.
6
Unbiased estimation of odds ratios: combining genomewide association scans with replication studies.优势比的无偏估计:将全基因组关联研究与重复研究相结合
Genet Epidemiol. 2009 Jul;33(5):406-18. doi: 10.1002/gepi.20394.
7
Unbiased estimation of selected treatment means in two-stage trials.两阶段试验中选定治疗均值的无偏估计。
Biom J. 2008 Aug;50(4):515-27. doi: 10.1002/bimj.200810442.
8
Drop-the-losers design: normal case.
Biom J. 2005 Jun;47(3):257-68; discussion 269-81. doi: 10.1002/bimj.200410119.